Cytokinetics Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC CYTK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

235,049

Value ($000)

14,935

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	14,935	0.0%	235,049	12/31/2025
2025 Q3	11/14/2025	13,101	0.0%	238,382	9/30/2025
2025 Q2	8/14/2025	13,753	0.0%	416,253	6/30/2025
2025 Q1	5/19/2025	12,415	0.0%	308,896	3/31/2025
2024 Q4	2/14/2025	14,829	0.0%	315,250	12/31/2024
2024 Q3	11/14/2024	14,085	0.0%	266,756	9/30/2024
2024 Q2	8/14/2024	13,650	0.0%	251,942	6/30/2024
2024 Q1	5/15/2024	8,268	0.0%	117,922	3/31/2024
2023 Q4	2/14/2024	9,732	0.0%	116,565	12/31/2023
2023 Q3	11/13/2023	3,560	0.0%	120,844	9/30/2023
2023 Q2	8/11/2023	4,066	0.0%	115,546	6/30/2023
2023 Q1	5/15/2023	4,066	0.0%	115,546	3/31/2023
2022 Q4	2/14/2023	4,458	0.0%	97,292	12/31/2022
2022 Q3	11/14/2022	3,962	0.0%	81,779	9/30/2022
2022 Q2	8/12/2022	3,907	0.0%	99,450	6/30/2022
2022 Q1	5/16/2022	3,447	0.0%	93,643	3/31/2022
2021 Q4	2/14/2022	4,292	0.0%	94,168	12/31/2021
2021 Q3	11/15/2021	2,481	0.0%	69,410	9/30/2021
2021 Q2	8/16/2021	1,245	0.0%	62,935	6/30/2021
2021 Q1	5/14/2021	1,475	0.0%	63,417	3/31/2021
2020 Q4	3/1/2021	1,113	0.0%	53,575	12/31/2020
2020 Q3	11/13/2020	1,146	0.0%	52,928	9/30/2020
2020 Q2	8/14/2020	1,141	0.0%	48,409	6/30/2020
2020 Q1	5/15/2020	700	0.0%	59,361	3/31/2020
2019 Q4	2/14/2020	495	0.0%	46,681	12/31/2019